Bimekizumab Treatment for Scalp Psoriasis: A 52-Week, Real-World, Retrospective Study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Irene,Stefanaki

第一单位： 1st Department of Dermatology and Venereology, National & Kapodistrian University of Athens, Medical School, "Andreas Sygros" Hospital for Skin Diseases, Athens, Greece.

作者： Irene,Stefanaki ^[1] ; Ioannis-Alexios,Koumprentziotis ^[1] ; Natalia,Rompoti ^[1] ; Pantelis,Panagakis ^[2] ; Charitomeni,Vavouli ^[1] ; Marina,Papoutsaki ^[1] ; Maria,Politou ^[1] ; Angeliki,Befon ^[2] ; Fiori,Kousta ^[2] ; Eleni,Lazou ^[2] ; Vasiliki,Chasapi ^[2] ; Alexander,Stratigos ^[1] ; Electra,Nicolaidou ^[1]

作者单位： 1st Department of Dermatology and Venereology, National & Kapodistrian University of Athens, Medical School, "Andreas Sygros" Hospital for Skin Diseases, Athens, Greece. ^[1] Department of Dermatology and Venereology, National Health System, "Andreas Sygros" Hospital for Skin and Venereal Diseases, Athens, Greece. ^[2]

关键词 bimekizumab biologic therapy interleukin‐17 scalp psoriasis

DOI 10.1111/ijd.17658

PMID 39821776

发布时间 2025-01-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

International journal of dermatology

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Bimekizumab Treatment for Scalp Psoriasis: A 52-Week, Real-World, Retrospective Study.

International journal of dermatology

相似文献

International journal of dermatology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Bimekizumab Treatment for Scalp Psoriasis: A 52-Week, Real-World, Retrospective Study.

International journal of dermatology

相似文献

International journal of dermatology

相关期刊

检索历史清除